Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS

Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS

<p>Abstract</p> <p>Background</p> <p>Anti-epileptic drugs (AEDs) are frequently prescribed to persons with HIV/AIDS receiving combination antiretroviral therapy (cART) although the extent of AED use and their interactions with cART are uncertain. Herein, AED usage, asso...

Full description

Bibliographic Details
Main Authors:	Krentz Hartmut B, Siemieniuk Reed A, Vivithanaporn Pornpun, Lee Kathy, Maingat Ferdinand, Gill M John, Power Christopher
Format:	Article
Language:	English
Published:	BMC 2010-06-01
Series:	BMC Neurology
Online Access:	http://www.biomedcentral.com/1471-2377/10/44

Similar Items

Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
by: Ballanyi Klaus, et al.
Published: (2011-06-01)

Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status.
by: William G Branton, et al.
Published: (2013-01-01)

Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity.
by: Pornpun Vivithanaporn, et al.
Published: (2010-09-01)

Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS.
by: Rakesh K Bhat, et al.
Published: (2014-01-01)

The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period
by: Hartmut B. Krentz, et al.
Published: (2012-01-01)

Establishing thresholds for important benefits considering the harms of screening interventions
by: Lise Mørkved Helsingen, et al.
Published: (2020-12-01)

Increasing HIV Subtype Diversity and Its Clinical Implications in a Sentinel North American Population
by: Reed AC Siemieniuk, et al.
Published: (2013-01-01)

The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study
by: Siemieniuk Reed AC, et al.
Published: (2011-11-01)

Topiramate as an anti-epileptic medication
by: S. G. Burd
Published: (2016-08-01)

Bone mineral density evaluation o epileptic children on anti-epileptic medications
by: Nasr Mohamed M. Osman, et al.
Published: (2017-12-01)

Carnitine deficiency in epileptic children treated with a diversity of anti-epileptic regimens
by: Sherine El Mously, et al.
Published: (2018-11-01)

Pro- and anti-epileptic roles of microglia
by: Shinichi Kinoshita, et al.
Published: (2021-01-01)

BIOMOLECULAR MECHANISM OF ANTI EPILEPTIC DRUGS
by: Machlusil Husna, et al.
Published: (2018-01-01)

Anti-Epileptic Drug Toxicity in Children
by: Imti Choonara
Published: (2018-05-01)

Trends in Anti-Epileptic Drug Development
by: Lennart Gram
Published: (1990-01-01)

Oxcabazepine (®Trileptal) in Anti-Epileptic Polytherapy
by: Peder Klosterskov Jensen
Published: (1990-01-01)

New anti-epileptic drugs in paediatrics
by: Ignacio Málaga, et al.
Published: (2019-12-01)

PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats
by: Ji-Eun Kim, et al.
Published: (2020-08-01)

Cadmium induces CCL2 production in glioblastoma cells via activation of MAPK, PI3K, and PKC pathways
by: Thitima Kasemsuk, et al.
Published: (2020-01-01)

Seizure threshold, hormones and anti epileptic drugs
by: Harsono Harsono
Published: (2008-03-01)

Pharmacokinetics of Anti-Epileptic Drugs and their Clinical Significance
by: Svein I. Johannessen
Published: (1990-01-01)

The effect of anti-epileptic drugs on the behaviour of the fetus
by: Lynch, Catherine
Published: (2012)

The Use of Anti-epileptic Drugs During Pregnancy
by: Chung-Lung Wang, et al.
Published: (2004)

The health system benefits of attending an HIV/AIDS conference
by: Alet Bosman, et al.
Published: (2017-06-01)

How do cancer screening guidelines trade off benefits versus harms and burdens of screening? A systematic survey
by: Lise Mørkved Helsingen, et al.
Published: (2020-12-01)

The benefits of HIV/AIDS intervention in the workplace: A case study
by: F. le R. Booysen, et al.
Published: (2002-03-01)

Factors Influencing Anti Epileptic Drug Non-Compliance
by: Dhanaraj M, et al.
Published: (2004-01-01)

Adherence of anti-epileptic drugs in pediatric patients in Taiwan
by: Shih-ChiehShao, et al.
Published: (2012)

The HIV-AIDS national security nexus : a history of risks and benefits
by: Feldbaume, Harley
Published: (2009)

The assessment of ENT1 inhibitors as potential anti-epileptic drugs
by: Hsiao-Ru Lin, et al.
Published: (2017)

Importance of competing risks in the analysis of anti-epileptic drug failure
by: Sander Josemir W, et al.
Published: (2007-03-01)

Anti epileptic drug usage and withdrawal in elderly persons with epilepsy
by: Jacob Nisha, et al.
Published: (2007-01-01)

Anti Epileptic Activity of Morinda citrifolia Linn Fruit Extract
by: P. Muralidharan, et al.
Published: (2010-01-01)

The teratogenic potential of anti-epileptic drugs and the implications for clinical practice
by: Morrow, James Irvine
Published: (2009)

Detection of anti-epileptic drug phenytoin by piezoresistive microcantilever biosensor
by: Lung-Yi Lin, et al.
Published: (2011)

A study of the causes of the anti-social behavior of epileptic adolescents
by: Sloan, Gertrude Q
Published: (2016)

Advance on synthesis, pharmacokinetics, and pharmacodynamics of the anti-epileptic drug: Levetiracetam
by: Wang Wei
Published: (2020-01-01)

Mucosal Immunity in the Female Genital Tract, HIV/AIDS
by: Juliana Reis Machado, et al.
Published: (2014-01-01)

Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents
by: Naofumi Kunisawa, et al.
Published: (2018-06-01)

Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.
by: Clare L Killick-Cole, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_vbqfs77p6e5q8n60bhe6bbc9br